Abstract
"Highly active antiretroviral therapy changed the paradigm of HIV infection, improving the prognosis of a deathly disease to a chronic manageable disease. Although the life expectancy of people with HIV is similar with general population, the persistence of inflammation is going to premature aging and excess comorbidities, relative to chronologic age. The mechanisms of immune dysfunction, inflammation, atherogenesis and dyslipidaemia in HIV positive people that are related to premature aging and cardiovascular risk, as well as the therapeutic strategies to prevent or improve the cardiovascular risk are reviewed in this communication. Keywords: HIV, inflammation, aging, cardiovascular risk, antiretroviral treatments"
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
